Charles Schwab Investment Management Inc. Increases Stock Position in Doximity, Inc. (NASDAQ:DOCS)

Charles Schwab Investment Management Inc. lifted its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 778,524 shares of the company's stock after buying an additional 25,523 shares during the period. Charles Schwab Investment Management Inc. owned about 0.42% of Doximity worth $41,565,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Handelsbanken Fonder AB lifted its stake in Doximity by 0.7% during the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company's stock valued at $1,586,000 after acquiring an additional 200 shares in the last quarter. UMB Bank n.a. grew its position in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after purchasing an additional 235 shares in the last quarter. Fielder Capital Group LLC grew its position in Doximity by 4.5% in the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company's stock worth $293,000 after purchasing an additional 235 shares in the last quarter. GAMMA Investing LLC increased its stake in Doximity by 20.6% in the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock valued at $93,000 after buying an additional 296 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC lifted its position in shares of Doximity by 17.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 2,269 shares of the company's stock worth $121,000 after buying an additional 332 shares in the last quarter. Institutional investors own 87.19% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on DOCS. KeyCorp decreased their price target on Doximity from $70.00 to $65.00 and set an "overweight" rating for the company in a research report on Wednesday, January 8th. Piper Sandler upgraded shares of Doximity from a "neutral" rating to an "overweight" rating and increased their price target for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. Leerink Partners raised shares of Doximity from a "market perform" rating to an "outperform" rating and increased their target price for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Finally, Bank of America lifted their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a report on Monday, January 6th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $64.22.

Doximity Trading Up 2.4 %

Shares of Doximity stock traded up $1.45 on Wednesday, reaching $62.76. The stock had a trading volume of 894,187 shares, compared to its average volume of 2,374,388. The business's 50 day moving average is $63.89 and its two-hundred day moving average is $53.07. The company has a market cap of $11.72 billion, a P/E ratio of 62.80, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.

Insider Buying and Selling at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 37.40% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.